Dr. Bermel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Building U10
Cleveland, OH 44195Phone+1 216-444-8600Fax+1 216-445-6259
Education & Training
Cleveland Clinic FoundationResidency, Neurology, 2003 - 2007
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2003
Certifications & Licensure
FL State Medical License 2024 - 2026
NY State Medical License 2024 - 2025
OH State Medical License 2003 - 2025
NV State Medical License 2012 - 2023- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Optical Coherence Tomography in Multiple Sclerosis Patients Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- 7 citationsProviding Person-Centered Care via Telemedicine in the Era of COVID-19 in Multiple SclerosisJustin R. Abbatemarco, Jennifer Hartman, Marisa P. McGinley, Robert A. Bermel, Adrienne Boissy
Journal of Patient Experience. 2021-01-01 - 90 citationsA semiautomated measure of whole-brain atrophy in multiple sclerosis.Robert A. Bermel, Jitendra Sharma, Christopher W. Tjoa, Srinivas R. Puli, Rohit Bakshi
Journal of the Neurological Sciences. 2003-04-15 - 193 citationsT2 Hypointensity in the Deep Gray Matter of Patients With Multiple Sclerosis: A Quantitative Magnetic Resonance Imaging StudyRohit Bakshi, Ralph H.B. Benedict, Robert A. Bermel, Shelton D. Caruthers, Srinivas R. Puli
Archives of Neurology. 2002-01-01
Journal Articles
- Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients with Alzheimer's and Parkinson's DiseaseHubert Fernandez, Justis P Ehlers, Jagan A Pillai, Sunil K Srivastava, Robert Bermel, James B Leverenz, Investigative Ophthalmology and Visual Science
Authored Content
- Optical Coherence Tomography Outcomes from SPRINT-MS, a Multicenter, Randomized, Double-Blind Trial of Ibudilast in Progressive Multiple SclerosisOctober 2020
Press Mentions
How B-cell Therapy Affects MSFebruary 7th, 2023- World-First Study Charts Brain Decline as We AgeApril 7th, 2022
- ADEM After COVID-19 Vaccine: Case ReportSeptember 17th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
